Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Kreis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Research Communications|February 24, 2026
Subclassification of Small Cell Lung Cancer Based on Gene Expression Signatures and Machine LearningNicole Kiedanski, Julian Kreis, Lucia Spangenberg, et al.
Cancer Research Communications|February 13, 2024
Stromal Signals Dominate Gene Expression Signature Scores That Aim to Describe Cancer Cell-intrinsic Stemness or Mesenchymality CharacteristicsJulian Kreis, Bogac Aybey, Felix Geist, et al.
Scientific Reports|June 12, 2020
Feature selection strategies for drug sensitivity predictionKrzysztof Koras, Dilafruz Juraeva, Julian Kreis, et al.
Nucleic Acids Research|April 22, 2016
EDGAR 2.0: an enhanced software platform for comparative gene content analysesJochen Blom, Julian Kreis, Sebastian Spänig, et al.
Nature Communications|December 14, 2023
Mapping combinatorial drug effects to DNA damage response kinase inhibitorsHanrui Zhang, Julian Kreis, Sven-Eric Schelhorn, et al.
Neoplasia (New York, N.Y.)|September 28, 2021
RosettaSX: Reliable gene expression signature scoring of cancer models and patientsJulian Kreis, Boro Nedić, Johanna Mazur, et al.
Breast Cancer Research : BCR|January 3, 2024
Identification of a Notch transcriptomic signature for breast cancerEike-Benjamin Braune, Felix Geist, Xiaojia Tang, et al.
Nucleic Acids Research|December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapyEeson Rajendra, Claudio A Lademann, Bethany Mason, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Research Communications|February 24, 2026
Subclassification of Small Cell Lung Cancer Based on Gene Expression Signatures and Machine LearningNicole Kiedanski, Julian Kreis, Lucia Spangenberg, et al.
Cancer Research Communications|February 13, 2024
Stromal Signals Dominate Gene Expression Signature Scores That Aim to Describe Cancer Cell-intrinsic Stemness or Mesenchymality CharacteristicsJulian Kreis, Bogac Aybey, Felix Geist, et al.
Scientific Reports|June 12, 2020
Feature selection strategies for drug sensitivity predictionKrzysztof Koras, Dilafruz Juraeva, Julian Kreis, et al.
Nucleic Acids Research|April 22, 2016
EDGAR 2.0: an enhanced software platform for comparative gene content analysesJochen Blom, Julian Kreis, Sebastian Spänig, et al.
Nature Communications|December 14, 2023
Mapping combinatorial drug effects to DNA damage response kinase inhibitorsHanrui Zhang, Julian Kreis, Sven-Eric Schelhorn, et al.
Neoplasia (New York, N.Y.)|September 28, 2021
RosettaSX: Reliable gene expression signature scoring of cancer models and patientsJulian Kreis, Boro Nedić, Johanna Mazur, et al.
Breast Cancer Research : BCR|January 3, 2024
Identification of a Notch transcriptomic signature for breast cancerEike-Benjamin Braune, Felix Geist, Xiaojia Tang, et al.
Nucleic Acids Research|December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapyEeson Rajendra, Claudio A Lademann, Bethany Mason, et al.
Pageof 1